유전체학 시장 : 제품 및 서비스, 기술, 최종 사용자, 용도별 - 세계 예측(2025-2030년)

The Genomics Market was valued at USD 27.36 billion in 2023, expected to reach USD 31.51 billion in 2024, and is projected to grow at a CAGR of 15.63%, to USD 75.63 billion by 2030.

The genomics market encompasses the research, development, and application of technologies that deal with the sequencing, analysis, and editing of genomes. It is integral for personalized medicine, agricultural advancements, and biotechnology innovations. The necessity of genomics lies in its potential to revolutionize healthcare by enabling precise medical interventions, predicting disease susceptibility, and developing targeted therapies. Beyond healthcare, its application extends to areas such as genetic engineering, biodiversity conservation, and forensic science. Emerging end-use sectors include pharmaceutical companies, research centers, academic institutions, and biotechnological companies. Key factors driving market growth include advancements in sequencing technologies, decreasing costs of sequencing, and an increasing demand for personalized medicine. Additionally, government initiatives supporting genomic research and a surge in collaborations between research institutions and key market players further stimulate this market. Potential opportunities include expansion in developing countries where healthcare infrastructure modernization is underway and the integration of AI and machine learning to enhance genomic data analysis accuracy and speed. Challenges facing the genomics market include ethical concerns over genetic data privacy, regulatory hurdles, and the complexity of data management. Furthermore, a lack of skilled professionals in genomics technology can slow market growth. Innovations and research in CRISPR technologies, novel therapeutics, and the development of consumer-friendly genomic testing kits present promising avenues for business growth. Companies focusing on improving data security, advancing bioinformatics tools, and establishing robust frameworks for genetic data management are likely to find significant strategic advantages. The nature of the genomics market is dynamic and highly competitive, characterized by rapid technological advancements and continuous new entrants. Building strategic partnerships, addressing ethical concerns, and investing in skilled workforce development are recommended strategies for leveraging opportunities in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genomics Market

The Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of government funding for the R&D in genome projects
  • Growing adoption of genomic medicine and precision public health
  • Development of genetic tools in agrigenomics
• Market Restraints
  • High cost of equipment and consumables
• Market Opportunities
  • Growth of newborn genetic screening programs and sequencing technologies
  • Adoption of advanced computational technologies to launch innovative products and services
• Market Challenges
  • Limited skilled and trained personnel

Porter's Five Forces: A Strategic Tool for Navigating the Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genomics Market

A detailed market share analysis in the Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genomics Market

A strategic analysis of the Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biomatters Limited, Bionano Genomics, Inc., C2i Genomics, Congenica Ltd., Danaher Corporation, Dante Labs Inc., Eagle Genomics, Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fabric Genomics, Inc., Helix OpCo, LLC, Merck & Co., Inc., Myriad Genetics, Inc., Nest Health Tech Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., QIAGEN GmbH, Quest Diagnostics Incorporated, Rapid Genomics by LGC Biosearch Technologies, Thermo Fisher Scientific Inc., and Vizgen, Inc..

Market Segmentation & Coverage

This research report categorizes the Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Consumables, Services, and Systems & Software.
• Based on Technology, market is studied across Microarray, Nucleic Acid Extraction & Purification, PCR, and Sequencing.
• Based on End-User, market is studied across Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic.
• Based on Application, market is studied across Agriculture & Animal Research, Diagnostics, and Drug Discovery & Development.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of government funding for the R&D in genome projects
    • 5.1.1.2. Growing adoption of genomic medicine and precision public health
    • 5.1.1.3. Development of genetic tools in agrigenomics
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of equipment and consumables
  • 5.1.3. Opportunities
    • 5.1.3.1. Growth of newborn genetic screening programs and sequencing technologies
    • 5.1.3.2. Adoption of advanced computational technologies to launch innovative products and services
  • 5.1.4. Challenges
    • 5.1.4.1. Limited skilled and trained personnel
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genomics Market, by Product & Service

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Services
• 6.4. Systems & Software

7. Genomics Market, by Technology

• 7.1. Introduction
• 7.2. Microarray
• 7.3. Nucleic Acid Extraction & Purification
• 7.4. PCR
• 7.5. Sequencing

8. Genomics Market, by End-User

• 8.1. Introduction
• 8.2. Government Institutes
• 8.3. Hospitals & Clinics
• 8.4. Pharmaceutical & Biotechnology Companies
• 8.5. Research Centers & Academic

9. Genomics Market, by Application

• 9.1. Introduction
• 9.2. Agriculture & Animal Research
• 9.3. Diagnostics
• 9.4. Drug Discovery & Development

10. Americas Genomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Genomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Genomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Biomatters Limited
• 5. Bionano Genomics, Inc.
• 6. C2i Genomics
• 7. Congenica Ltd.
• 8. Danaher Corporation
• 9. Dante Labs Inc.
• 10. Eagle Genomics
• 11. Eppendorf SE
• 12. Eurofins Scientific SE
• 13. F. Hoffmann-La Roche AG
• 14. Fabric Genomics, Inc.
• 15. Helix OpCo, LLC
• 16. Merck & Co., Inc.
• 17. Myriad Genetics, Inc.
• 18. Nest Health Tech Inc.
• 19. Novogene Co., Ltd.
• 20. Oxford Nanopore Technologies PLC
• 21. Pacific Biosciences of California, Inc.
• 22. Personalis, Inc.
• 23. QIAGEN GmbH
• 24. Quest Diagnostics Incorporated
• 25. Rapid Genomics by LGC Biosearch Technologies
• 26. Thermo Fisher Scientific Inc.
• 27. Vizgen, Inc.